Motley Fool January 31, 2020
Keith Speights

An exciting new discovery holds the potential to completely disrupt the healthcare industry as we know it.

Every now and then, I’ll see an article online about some scientist who has supposedly made a breakthrough discovery that could cure cancer. Almost exactly one year ago, I read about Israeli scientists who believed they had identified peptides — which are similar to proteins but smaller — that could cure cancer.

The chairman of the board of the biotech researching the potential therapy even told The Jerusalem Post that his company “will offer in a year’s time a complete cure for cancer.” I was very skeptical at the time (as were many others). And, sure enough, the Israeli...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Physician, Precision Medicine, Provider, Technology
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article